Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Topical Roflumilast for Pediatric Morphea.

Journal of cutaneous medicine and surgery·2026
Same author

Cross-Sectional Survey of Unmet Needs in Children With NF1 and Cutaneous Neurofibromas: The Role of Pediatric Dermatology.

Pediatric dermatology·2026
Same author

What is the treatment pattern of juvenile systemic sclerosis? Results from an international cohort.

Journal of scleroderma and related disorders·2026
Same author

Pediatric morphea: MRI evaluation of superficial and deep tissue involvement and impact in clinical practice.

Pediatric radiology·2026
Same author

Intravenous immunoglobulin for the treatment of morphea in pediatric patients: A case series.

JAAD case reports·2026
Same author

Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.

Arthritis care & research·2026

Related Experiment Video

Updated: Jul 18, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

Childhood acquired lipodystrophy: a retrospective study.

Elena Pope1, Allison Janson, Amina Khambalia

  • 1Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. elena.pope@sickkids.ca

Journal of the American Academy of Dermatology
|November 14, 2006
PubMed
Summary

Children with acquired lipodystrophy (LD) often have autoimmune conditions. Early diagnosis of LD in children increases the risk of complications, necessitating vigilant monitoring.

More Related Videos

Human Subcutaneous Adipose Tissue Sampling Using a Mini-Liposuction Technique
08:59

Human Subcutaneous Adipose Tissue Sampling Using a Mini-Liposuction Technique

Published on: September 27, 2021

Related Experiment Videos

Last Updated: Jul 18, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

Human Subcutaneous Adipose Tissue Sampling Using a Mini-Liposuction Technique
08:59

Human Subcutaneous Adipose Tissue Sampling Using a Mini-Liposuction Technique

Published on: September 27, 2021

Area of Science:

  • Pediatric Endocrinology
  • Autoimmune Diseases
  • Dermatology

Background:

  • Acquired lipodystrophy (LD) is a rare condition characterized by loss of adipose tissue.
  • Understanding the clinical spectrum and complications in children is crucial for early intervention.

Purpose of the Study:

  • To delineate the clinical features and associated complications of acquired lipodystrophy in pediatric patients.
  • To identify potential risk factors for developing complications in childhood LD.

Main Methods:

  • Retrospective chart review of pediatric patients diagnosed with acquired LD between 1997 and 2004.
  • Analysis of clinical characteristics, underlying diagnoses, and documented complications.

Main Results:

  • Twenty-three pediatric patients with acquired LD were identified, with a mean age at diagnosis of 9.7 years; 61% were female.
  • Dermatomyositis was the most frequent underlying diagnosis (78%). Common complications included acanthosis nigricans (22%) and hepatomegaly (13%).
  • Younger age at diagnosis (mean 7 years) was significantly associated with an increased risk of complications compared to older children (mean 12 years).

Conclusions:

  • Childhood acquired LD is frequently linked to autoimmune disorders.
  • Pediatric patients diagnosed with LD, especially at a younger age, require close monitoring for potential complications.